Arcutis Biotherapeutics, Inc. (ARQT)

29.31 -0.59 (-1.97%) USD  |  NASDAQ  |  Dec 23, 16:00
29.26 -0.05 (-0.17%) Pre-Market: 08:53
More

Arcutis Biotherapeutics SG&A Expense (TTM): 253.18M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
CorMedix, Inc. 75.56M
ADMA Biologics, Inc. 96.37M
ANI Pharmaceuticals, Inc. 304.67M
Editas Medicine, Inc. 54.90M
Amicus Therapeutics, Inc. 353.07M